Click directly to the article...
Epagogix - a "weapon of choice" in helping executives to make tough decisions, says BBC article
MovieArb -- a new film investment vehicle -- is using Epagogix to provide key forecasting information.
Ted.com (Technology, Entertainment, Design) How algorithms shape our world.
Ira Basen of Canada's The Globe and Mail notes Epagogix's accuracy and usefulness for studios...
BBC Focus on Epagogix and "the top five automated talent spotters"...
Boom magazine's editor reviews Epagogix.
Motley Fool says - "...data mining is transforming the commercial place [its practitioners] throw a healthy dose of cold water on conventional wisdom.
One of the more unusual and innovative ways computer number-crunching has been put to use comes out of Hollywood.
Epagogix are "Super Crunchers" asserts Professor Ian Ayres in his acclaimed new book on Why Thinking-By-Numbers Is The New Way To Be Smart.
"Hollywood is an intensely risky business...there is certainly an openness to what [Epagogix] is talking about..." says Variety's Steven Gaydos in an interview with BBC Radio 5 Live.
FLOPBUSTERS! Britain's famous Sun newspaper gives a uniquely succinct take on Epagogix's value proposition.
La Science du "blockbuster" - an overview of Epagogix in Montreal's Le Soleil.
"Nobody knows everything" ...that’s what the computers are there for, says The Guardian (UK).
Malcolm Gladwell, noted author of 'Blink' and 'The Tipping Point' aims his pen at Epagogix... What if you built a machine to predict hit movies?... 'It was incredible [the accuracy of Epagogix's forecasts] ...it was like someone saying to you 'We’re going to show you how to count cards in Vegas'. - Senior Warner Brothers Executive quoted by Malcolm Gladwell in The New Yorker Magazine, Oct 16th 2006.
Epagogix reported on "In Business" - BBC Radio 4’s industry innovations programme (MP3 11.4 MB).
'This is an incredibly valuable tool' - Watch a video of Malcolm Gladwell describing Epagogix’s unique abilities.
Is there a formula to predict Oscar Winners? Deutsche Welle Radio’s Matthew Lawton asks Epagogix’s Nick Meaney this timely question and investigates other aspects of the 'artistic' versus the 'commercial' imperatives of film-making (MP3 3.43 MB).
Peter Körte, the well-respected cultural editor of the Frankfurter Allgemeine Sonntagszeiting takes an in-depth look at Hollywood and interviews Nick Meaney and Sean Verity, members of Epagogix’s team about the potential impact of their services.
Malcolm Gladwell’s groundbreaking analysis of the impact and implications of Epagogix’s approach translated into the German language by Switzerland’s Neue Zurcher Zeitung, NZZ online.
The Independent newspaper - Epagogix role in changing Hollywood environment.
Marco de Martino provides a summary overview of Epagogix’s methodology for the news website Panorama.itCharles Hummel: "Aristotle (384-322 B.C.)."
Providing tools to help clients make the best decisions.
Epagogix is a privately-held UK company, with representation in the USA. Epagogix brings together expertise in risk, finance, artificial intelligence and film analysis to create innovative tools and solutions for the hard decisions that senior company directors need to make.
By understanding the critical risks facing a business, identifying the data around those risks, and developing customised artificial intelligence solutions, we help clients to better predict outcomes.
Our forecasts help clients to make the best objective decisions about spending risk capital and managing operational budgets.
Successfully addressing big decisions concerning key risks can have profound strategic consequences and influence market performance.
Epagogix’s primary focus is on the film and TV sectors. We work with major Hollywood studios, and with independents. We have expertise and impeccable contacts in the field of movie fund-raising. Increasingly Epagogix is invited to assist companies in making critical decisions in other data-rich areas.
Epagogix is noted for its discretion.
Prof. Ian Ayres, Super Crunchers, published by Bantam Books, a Division of Random House Inc. ISBN 978-0-553-80540-6